During the past decade, Rush Eye Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Rush Eye Associates" are "Astigmatism" (1 trials), "Blepharitis" (1 trials), "Corneal Ectasia Disorders Including Keratoconus" (1 trials), "Dry Eye" (1 trials) and "Dry Eye Syndromes" (1 trials). Many other conditions were trialed in "Rush Eye Associates" in a lesser frequency.

Most popular intervention types in "Rush Eye Associates" are "Drug" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "CXL" (1 trials), "Contoura Vision LASIK" (1 trials) and "Corneal Epithelial Stem Cell Transplant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rush Eye Associates" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Rush Eye Associates". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Rush Eye Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rush Eye Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".